LBO — PALESTINE REGIONAL MEDICAL CENTER
IRR: 29.6% | MOIC: 3.65x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
29.6%
IRR
3.65x
MOIC
$25.8M
Entry EV
$61.0M
Exit EV
$13.3M
Equity Invested
Sources & Uses
S&UTotal · $25.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $10.0M | 38.8% | |
| Sub Debt | $2.5M | 9.7% | |
| Equity | $13.3M | 51.5% | |
| Enterprise Value | $25.1M | 97.1% | |
| Transaction Fees | $0.8M | 2.9% | |
| Total Uses | $25.8M | 100.0% |
Interpretation
INTAt 3.65x MOIC and 29.6% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $5.8M |
| Exit Ev | $61.0M |
| Net Debt At Exit | $12.5M |
| Equity At Exit | $48.5M |
| Equity Invested | $13.3M |
| Total Value Created | $35.2M |
| Value From Growth | $34.7M |
| Value From Multiple | $1.3M |
| Value From Deleveraging | $0.0M |